Assistant Controller

Damora Therapeutics, Inc. (Nasdaq: DMRA) is a Boston-based biotechnology company working to fundamentally redefine care for patients with blood disorders. Damora is advancing a new generation of subcutaneous biologics targeting mutant calreticulin (mutCALR)-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis — chronic hematologic cancers with significant unmet need. The company’s lead program, DMR-001, is an investigational monoclonal antibody designed to selectively target mutant calreticulin, with additional programs (DMR-002 and DMR-003) advancing behind it.

Damora is preparing for first-in-human dosing of DMR-001 in 2026 and is funded into 2H 2029. As the Company scales its finance organization to meet the reporting and internal control demands of an SEC registrant — including its first SOX Section 404(b) auditor attestation — this role is central to building that foundation.

We are open to candidates that are able to work hybrid (2-3 days onsite) in Boston or San Francisco. The Assistant Controller owns the day-to-day execution of Damora's accounting operations, partnering closely with and reporting to the Controller. Where the Controller sets the Company's accounting positions, owns external SEC reporting, designs the control environment, and drives the use of AI across the function, the Assistant Controller is the hands-on operator who delivers against that framework — closing the books, assembling filings and support, implementing accounting conclusions, and operating controls day to day.

This role is the natural counterpart to the Controller. You bring the operational discipline and execution rigor that allow the function to close cleanly, file on time, and keep controls intact as the Company grows. You will frequently be responsible on the ground for day-to-day decisions, and you will be trusted to act with judgment within the policies and positions the Controller establishes.

• Own and execute the monthly, quarterly, and annual close in Flo Qast, maintaining the close calendar and driving the cycle toward a predictable, shortened timeline.
• Prepare and review journal entries with complete supporting documentation, including accruals, prepaids, R&D and clinical trial accruals, stock-based compensation, and depreciation.
• Review the payroll register and related payroll journal entries prior to posting, serving as backup reviewer to the Controller.
• Prepare and review balance sheet reconciliations and resolve reconciling items, keeping the general ledger accurate and audit-ready.
• Prepare and review monthly cash and investment account reconciliations, monitoring balances against forecast and flagging unusual or unsupported activity.
• Perform flux and variance analysis on income statement and balance sheet accounts and provide commentary to the Controller and FP&A.
• Support the Controller in the preparation of all SEC filings — including quarterly 10-Qs and the annual 10-K with footnote disclosures — built and maintained in Active Disclosure, in compliance with US GAAP and SEC requirements.
• Assemble and tie out the financial statements and footnotes within Active Disclosure, prepare support files, complete disclosure checklists and questionnaires, and manage XBRL tagging for the Controller's review.
• Gather information across departments, coordinate review comments across drafts, and monitor progress against the quarterly reporting timetable and reporting-cycle milestones.

• Support the Controller, as head of technical accounting, in evaluating new contracts, transactions, and events and in assessing new accounting guidance; assist with researching and drafting…